Le Roger was evaluated in a medical setting at a university clinic in Belgium. Various tests were conducted on patients diagnosed with erectile dysfunction linked to cavernous-venous leakage. Urologists, perineal physiotherapists, etc. Working alongside healthcare professionals, we then perfected the device with one simple requirement: to enhance its reliability and safety without ever altering the natural rhythm of sexual activity.
Rigorous preliminary and clinical trials were conducted in 2017-2018 in a Belgian urology department.
And the results lived up to expectations!
Dr. R. ANDRIANNE, clinical urologist and Professor of Sexual Medicine at the University of Liège, certifies that he has evaluated the effectiveness of the pelvic constrictor in clinical trials. He shares his testimony with us after conducting several evaluations on the prototype.
In his letter, he emphasizes that this “simple but clever” device provides help in certain situations of erectile dysfunction and has an interesting influence on blocking cavernous-venous leakage:
“I can confirm that the prototype tested provides a consistent improvement in venous leakage problems according to the results of PCDM (pharmaco-caverno-flowmetry) tests, which enable the leakage in question to be quantified scientifically.”
“Similarly, we observed a statistically significant increase in the EHS (Erection Hardness Score) when wearing the device during PCDM (pharmaco-caverno-flowmetry).”
